Features Screener Stocks Charts
Sign In Sign Up

Indoco Remedies Limited Income Statement

NSE:INDOCO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year INDOCO income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 18.27B 16.65B
Cost of Revenue -5.59B -4.98B
Gross Profit 12.68B 11.67B
Sales, General & Admin -10.14B -4.70B
Operating Income 1.62B -145.87M
Profit Before Tax 1.36B -743.71M
Net Income 970.10M -779.51M
Diluted Shares 92.26M 92.29M
Diluted EPS 10.51 -8.45

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025